This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignees: Fondazione Italiana Sclerosi Multipla—fism Onlus, Universita′ Degli Studi Di Milano. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 40 Years Active: 2018
Title: Chiara Parravicini: Innovator in Neuroprotective Compounds
Introduction
Chiara Parravicini is an accomplished inventor based in Milano, Italy. She has made significant contributions to the field of neuroprotective compounds, focusing on the modulation of the GPR17 receptor. Although she currently holds no granted patents, her research and applications are noteworthy.
Latest Patent Applications
Chiara's latest patent applications include "GPR17-Modulating Compounds, Diagnostic and Therapeutic Uses Thereof." This application discloses compounds that can modulate the activity of the GPR17 receptor in a highly specific manner. These compounds are useful in the treatment and diagnosis of diseases or dysfunctions involving the activation of the GPR17 receptor. In particular, they can be utilized for neuroprotective and reparatory purposes in conditions such as cerebral, cardiac, and renal ischemia, as well as in chronic neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) and demyelinating diseases such as multiple sclerosis.
Conclusion
Chiara Parravicini is a promising inventor whose work in neuroprotective compounds has the potential to impact various medical fields significantly. Her ongoing research and patent applications reflect her dedication to advancing therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile